查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2032526

上市後藥物監測和藥品資訊市場報告：按類型、產品類型、最終用戶和地區分類（2026-2034 年）

Post-marketing Pharmacovigilance and Medical Information Market Report by Type, Product, End User, and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 137 Pages | 商品交期: 2-3個工作天內

價格

2025年，全球上市後藥物監測和醫療保健資訊市場規模達67億美元。展望未來，IMARC Group預測，到2034年，該市場規模將達到145億美元，2026年至2034年的複合年成長率為8.68%。

上市後藥物監測和醫學資訊是指在藥物和醫療設備上市後對其安全性和有效性進行監測的活動。這包括收集、監測和預防新藥、醫療設備和治療方法的副作用。這有助於明確風險獲益比並排除誤標適應症，從而保護患者免受不必要的傷害。此外，它還有助於研究人員確定藥物研發週期中所需的各項措施。因此，上市後藥物監測和醫學資訊在醫療保健產業中發揮著至關重要的作用，有助於評估患者與醫療專業人員之間資訊的準確性。它也用於規範研究機構的藥物安全指南。

上市後藥物監測與醫療資訊市場趨勢：

全球人口老化以及糖尿病、高血壓、失智症、心血管疾病和骨質疏鬆症等各種慢性疾病發生率的上升是推動藥品消費成長的主要因素。此外，文明病、呼吸系統和心血管感染疾病以及神經系統疾病和腫瘤疾病的日益普遍也促進了全球藥品銷售的成長。這些因素共同造就了良好的市場前景。同時，不利事件（ADR）發生率的上升以及先進ADR報告工具的日益普及也支撐著市場成長。此外，醫院、診所、實驗室和醫學研究中心的擴張也推動了全球對藥品和醫療設備的需求。同時，世界各國政府正在實施各種舉措，以改善醫療基礎設施和藥物安全監測服務，並維護醫療資料庫，這些舉措也促進了市場成長。此外，主要市場參與者正致力於將藥物安全監測業務外包，並採用基於雲端的醫療資訊系統。這些措施有望推動市場發展，旨在最佳化準確性、提高成本效益、降低風險、增強專業技能、縮短處理時間並提高組織靈活性。

目錄

第1章：序言

第2章：調查方法

  • 調查目的
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 次要訊息
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章執行摘要

第4章：引言

第5章：全球上市後藥物監測與藥品資訊市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場預測

第6章 市場區隔：依類型

  • 自願報告
  • 加強ADR報告
  • 有針對性的自願報告
  • 佇列心臟事件記錄器
  • 電子健康記錄挖掘

第7章 市場區隔：依產品分類

  • 圖書
  • 網路媒體
  • 日誌

第8章 市場區隔：依最終用戶分類

  • 醫院
  • 研究機構

第9章 市場區隔：依地區分類

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第10章 SWOT 分析

第11章：價值鏈分析

第12章：波特五力分析

第13章：價格分析

第14章 競爭格局

  • 市場結構
  • 大公司
  • 主要公司簡介
    • Accenture Plc.
    • ArisGlobal
    • Cognizant Technology Solutions Corporation
    • Ergomed Plc
    • F. Hoffmann-La Roche Ltd.
    • Icon Plc
    • Parexel International Corporation
    • Pharmaceutical Product Development, Inc.
    • Wipro Ltd.
Product Code: SR112026A6454

The global post-marketing pharmacovigilance and medical information market size reached USD 6.7 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 14.5 Billion by 2034, exhibiting a growth rate (CAGR) of 8.68% during 2026-2034.

Post-marketing pharmacovigilance and medical information is the practice of monitoring the safety and efficacy of drugs and medical devices after their launch. It includes collection, surveillance, and prevention of adverse effects of new medicines, equipment, and therapies. It helps protect patients from unnecessary harm by clarifying risks concerning benefits and refuting false indications. Besides this, it assists researchers in determining required actions throughout the drug formulation cycle. As a result, post-marketing pharmacovigilance and medical information finds a considerable role in the healthcare industry to assess the accuracy of the delivered information between patients and medical professionals. It is also used in research organizations for regulating drug safety guidelines.

POST-MARKETING PHARMACOVIGILANCE AND MEDICAL INFORMATION MARKET TRENDS:

The growing global geriatric population and the rising occurrence of various chronic medical disorders, such as diabetes, hypertension, dementia, cardiovascular diseases, and osteoporosis, represent one of the key factors increasing the consumption of medicines. In addition, the increasing frequency of lifestyle, respiratory and cardiovascular infections, and neurological and oncological diseases are resulting in the increasing sales of drugs worldwide. This, in turn, is creating a positive market outlook. In line with this, the rising prevalence of Adverse Drug Reactions (ADRs), coupled with the incorporation of advanced ADR reporting tools, is supporting the market growth. Apart from this, the expansion of hospitals, clinics, laboratories, and medical research centers is catalyzing the demand for medications and medical devices across the globe. Moreover, governments of various countries are implementing several initiatives to improve healthcare infrastructure and pharmacovigilance services and maintain medical databases, which is strengthening the market growth. Furthermore, leading market players are focusing on outsourcing pharmacovigilance operations (PVO) and introducing cloud-based medical information systems for optimal accuracy, cost efficiency, risk mitigation, domain, improved timelines, and organizational agility, which is anticipated to drive the market.

KEY MARKET SEGMENTATION:

Breakup by Type:

  • Spontaneous Reporting
  • Intensified ADR Reporting
  • Targeted Spontaneous Reporting
  • Cohort Event Monitoring
  • EHR Mining

Breakup by Product:

  • Books
  • Online Media
  • Journals

Breakup by End User:

  • Hospitals
  • Research Organization

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

COMPETITIVE LANDSCAPE:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Accenture Plc., ArisGlobal, Cognizant Technology Solutions Corporation, Ergomed Plc, F. Hoffmann-La Roche Ltd., Icon Plc, Parexel International Corporation, Pharmaceutical Product Development, Inc. and Wipro Ltd.

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Post-marketing Pharmacovigilance and Medical Information Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Spontaneous Reporting
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Intensified ADR Reporting
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Targeted Spontaneous Reporting
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Cohort Event Monitoring
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 EHR Mining
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by Product

  • 7.1 Books
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Online Media
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Journals
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Research Organization
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Accenture Plc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 ArisGlobal
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Cognizant Technology Solutions Corporation
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Ergomed Plc
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
    • 14.3.5 F. Hoffmann-La Roche Ltd.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 SWOT Analysis
    • 14.3.6 Icon Plc
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Parexel International Corporation
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 SWOT Analysis
    • 14.3.8 Pharmaceutical Product Development, Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 SWOT Analysis
    • 14.3.9 Wipro Ltd.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials

List of Figures

  • Figure 1: Global: Post-marketing Pharmacovigilance and Medical Information Market: Major Drivers and Challenges
  • Figure 2: Global: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Billion USD), 2020-2025
  • Figure 3: Global: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 4: Global: Post-marketing Pharmacovigilance and Medical Information Market: Breakup by Type (in %), 2025
  • Figure 5: Global: Post-marketing Pharmacovigilance and Medical Information Market: Breakup by Product (in %), 2025
  • Figure 6: Global: Post-marketing Pharmacovigilance and Medical Information Market: Breakup by End User (in %), 2025
  • Figure 7: Global: Post-marketing Pharmacovigilance and Medical Information Market: Breakup by Region (in %), 2025
  • Figure 8: Global: Post-marketing Pharmacovigilance and Medical Information (Spontaneous Reporting) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 9: Global: Post-marketing Pharmacovigilance and Medical Information (Spontaneous Reporting) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 10: Global: Post-marketing Pharmacovigilance and Medical Information (Intensified ADR Reporting) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 11: Global: Post-marketing Pharmacovigilance and Medical Information (Intensified ADR Reporting) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 12: Global: Post-marketing Pharmacovigilance and Medical Information (Targeted Spontaneous Reporting) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 13: Global: Post-marketing Pharmacovigilance and Medical Information (Targeted Spontaneous Reporting) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 14: Global: Post-marketing Pharmacovigilance and Medical Information (Cohort Event Monitoring) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 15: Global: Post-marketing Pharmacovigilance and Medical Information (Cohort Event Monitoring) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 16: Global: Post-marketing Pharmacovigilance and Medical Information (EHR Mining) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 17: Global: Post-marketing Pharmacovigilance and Medical Information (EHR Mining) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 18: Global: Post-marketing Pharmacovigilance and Medical Information (Books) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 19: Global: Post-marketing Pharmacovigilance and Medical Information (Books) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 20: Global: Post-marketing Pharmacovigilance and Medical Information (Online Media) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 21: Global: Post-marketing Pharmacovigilance and Medical Information (Online Media) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 22: Global: Post-marketing Pharmacovigilance and Medical Information (Journals) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 23: Global: Post-marketing Pharmacovigilance and Medical Information (Journals) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 24: Global: Post-marketing Pharmacovigilance and Medical Information (Hospitals) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 25: Global: Post-marketing Pharmacovigilance and Medical Information (Hospitals) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 26: Global: Post-marketing Pharmacovigilance and Medical Information (Research Organization) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 27: Global: Post-marketing Pharmacovigilance and Medical Information (Research Organization) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 28: North America: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 29: North America: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 30: United States: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 31: United States: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 32: Canada: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 33: Canada: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 34: Asia-Pacific: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 35: Asia-Pacific: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 36: China: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 37: China: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 38: Japan: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 39: Japan: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 40: India: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 41: India: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 42: South Korea: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 43: South Korea: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 44: Australia: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 45: Australia: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 46: Indonesia: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 47: Indonesia: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 48: Others: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 49: Others: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 50: Europe: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 51: Europe: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 52: Germany: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 53: Germany: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 54: France: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 55: France: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 56: United Kingdom: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 57: United Kingdom: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 58: Italy: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 59: Italy: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 60: Spain: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 61: Spain: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 62: Russia: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 63: Russia: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 64: Others: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 65: Others: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 66: Latin America: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 67: Latin America: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 68: Brazil: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 69: Brazil: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 70: Mexico: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 71: Mexico: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 72: Others: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 73: Others: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 74: Middle East and Africa: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 75: Middle East and Africa: Post-marketing Pharmacovigilance and Medical Information Market: Breakup by Country (in %), 2025
  • Figure 76: Middle East and Africa: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 77: Global: Post-marketing Pharmacovigilance and Medical Information Industry: SWOT Analysis
  • Figure 78: Global: Post-marketing Pharmacovigilance and Medical Information Industry: Value Chain Analysis
  • Figure 79: Global: Post-marketing Pharmacovigilance and Medical Information Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Post-marketing Pharmacovigilance and Medical Information Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Breakup by Type (in Million USD), 2026-2034
  • Table 3: Global: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Breakup by Product (in Million USD), 2026-2034
  • Table 4: Global: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Breakup by End User (in Million USD), 2026-2034
  • Table 5: Global: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 6: Global: Post-marketing Pharmacovigilance and Medical Information Market: Competitive Structure
  • Table 7: Global: Post-marketing Pharmacovigilance and Medical Information Market: Key Players